Union Ambroxol Injection (Ambroxol Hydrochloride)

Adult administration

As ambroxol hydrochloride, administer 15 mg per dose for intravenous injection 2 to 3 times a day slowly. In severe cases, it can be increased to 30 mg per dose, infused slowly with normal saline or Ringer's solution.

Child administration

Ages 5 and above: 15 mg per dose for intravenous injection 2 to 3 times a day. Ages 2 to 4: 7.5 mg per dose for intravenous injection 3 times a day. Under 2 years: 7.5 mg per dose for intravenous injection 2 times a day. Pediatric:

This medication should be opened carefully when using a glass ampoule, as glass fragments may mix in, especially when administering to children or the elderly. It should not be used in patients with allergic reactions to this drug or any of its components. Caution is required when administering to patients with poor kidney function or severely impaired liver function, as well as to children under 2 years of age. Serious skin conditions may occur rarely with this medication, so if any abnormalities on the skin or mucous membranes arise, use should be discontinued immediately and appropriate treatment sought. Gastrointestinal discomfort, nausea, vomiting, heartburn, dry mouth, abdominal discomfort, stomach or abdominal bloating, stomach pain, diarrhea, constipation, loss of appetite, skin rash, urticaria-like erythema, itching, facial swelling, fever accompanied by chills, purulent rhinitis with increased white blood cell count, sensory disturbances of the tongue, taste changes, oral paralysis symptoms, arm numbness, headache, leg pain, and extreme fatigue may occur. Rarely, skin rashes or severe allergic reactions may arise, and if symptoms such as facial swelling, difficulty breathing, or hives develop, medical personnel should be notified immediately. Inflammation of the respiratory tract may occur, and rare neurological symptoms such as changes in tongue sensation or taste, arm numbness have been reported. When used with antibiotics, increased secretion in the bronchi or lungs may heighten antibiotic concentration, so caution is advised. Use during pregnancy, especially in the first trimester, is not recommended, and if nursing, it should be used cautiously after consultation with a doctor, as this medication can be transmitted through breast milk. Elderly patients may have decreased bodily function, necessitating a reduction in dosage or careful monitoring during use. No unusual symptoms have been reported in cases of overdose, but if abnormal symptoms occur, immediate consultation with healthcare professionals and symptomatic treatment should be sought. When injecting, headache, leg pain, and extreme fatigue may occur, therefore slow injection is advisable. This medication can only be mixed with normal saline injection or Ringer's solution for intravenous infusion and should be used within 24 hours of mixing. Keep this medication out of the reach of children.

Serious side effects

• Urticaria
• angioedema
• difficulty breathing
• severe acute anaphylactic reactions
• Stevens-Johnson syndrome
• toxic epidermal necrolysis.

Mild side effects

Indigestion, nausea, vomiting, heartburn, dry mouth, discomfort in the stomach, stomach and abdominal bloating, stomach pain, diarrhea, constipation, loss of appetite, skin rash, urticaria-like erythema, itching, facial swelling, fever accompanied by chills, purulent rhinitis with increased white blood cell count, sensory disturbances of the tongue, taste changes, oral numbness, arm numbness, headache, leg pain, extreme fatigue.

This medication is sensitive to light, so it should be stored in a container that does not allow light exposure. It is best stored at room temperature between 1 and 30 degrees Celsius.

Appearance

Brown ampoule filled with a colorless liquid

Package unit

For domestic use - 2 milliliters/ampoule [2mL x 100 ampoules], for export - 2 milliliters/ampoule [2mL x 10 ampoules]